BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer
HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. “A Total Artificial Heart (TAH) is unique in its complexity and importance as an advanced treatment option for end-stage biventricular heart failure patients. The … Continue reading BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer